Home >
NEWS
COVID-19 tracker: CureVac sees hope for vaccine despite trial flop; AZ jab highly protective against death in older adults
release time：2021-07-02
CureVac said its vaccine, only 48% effective in late-stage clinical trials, could still pose a "strong public health value."
Two doses of AstraZeneca's vaccine prevent roughly 94% of deaths in older people, according to Public Health England.
The worldwide case count stood at more than 182.4 million on Thursday afternoon, with more than 3.9 million reported deaths, according to Johns Hopkins University's COVID-19 dashboard.
Copyright Copyright (C) 2015-2035 Senova Technology Co. Ltd.
Address: Room2012, Tower A of Shangmei International Building, 1355# Liuxian Avenue, Nanshan Dist., Shenzhen, China 518055 Tel: +86-0755-8670 3119 QQ: 530953397 Email: info@senovatech.com
Address: Room2012, Tower A of Shangmei International Building, 1355# Liuxian Avenue, Nanshan Dist., Shenzhen, China 518055 Tel: +86-0755-8670 3119 QQ: 530953397 Email: info@senovatech.com